Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rick Bedlack. (2019) ALSUntangled 48: Perampanel (Fycompa). Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:5-6, pages 453-456.
Read now
Read now
Verena C Haringer & Summer B Gibson. (2015) Amyotrophic lateral sclerosis: clinical perspectives. Orphan Drugs: Research and Reviews 5, pages 19-31.
Read now
Read now
Abigail DeLoach, Michael Cozart, Arianna Kiaei & Mahmoud Kiaei. (2015) A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies. Expert Opinion on Drug Discovery 10:10, pages 1099-1118.
Read now
Read now
Articles from other publishers (21)
Marina N. Vukolova, Laura Y. Yen, Margarita I. Khmyz, Alexander I. Sobolevsky & Maria V. Yelshanskaya. (2023) Parkinson’s disease, epilepsy, and amyotrophic lateral sclerosis—emerging role of AMPA and kainate subtypes of ionotropic glutamate receptors. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Zeynep YILDIRIM, Dicle Naz TOKTAŞ, Öznur DEMİR, Zülfiye GÜL & Burcu ŞEN UTSUKARÇİ. (2023) Amyotrofik Lateral Skleroz Patofizyolojisi ve Tedavi YaklaşımlarıAn Evaluation of Amyotrophic Lateral Sclerosis and Current Situation in Its Treatment. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Belgin Sever, Halilibrahim Ciftci, Hasan DeMirci, Hilal Sever, Firdevs Ocak, Burak Yulug, Hiroshi Tateishi, Takahisa Tateishi, Masami Otsuka, Mikako Fujita & Ayşe Nazlı Başak. (2022) Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:5, pages 2400.
Crossref
Crossref
Rupinder Kaur Sodhi, Amarjot Kaur Grewal, Jitender Madan, Thakur Gurjeet Singh Jhajj & Rishab Kumar. 2021. Clinical Perspectives and Targeted Therapies in Apoptosis. Clinical Perspectives and Targeted Therapies in Apoptosis
217
283
.
Valéria Meszlényi, Roland Patai, Tamás F. Polgár, Bernát Nógrádi, Laura Körmöczy, Rebeka Kristóf, Krisztina Spisák, Kornélia Tripolszki, Márta Széll, Izabella Obál, József I. Engelhardt & László Siklós. (2020) Passive Transfer of Sera from ALS Patients with Identified Mutations Evokes an Increased Synaptic Vesicle Number and Elevation of Calcium Levels in Motor Axon Terminals, Similar to Sera from Sporadic Patients. International Journal of Molecular Sciences 21:15, pages 5566.
Crossref
Crossref
Gitika Batra, Manav Jain, RahulSoloman Singh, AmitRaj Sharma, Ashutosh Singh, Ajay Prakash & Bikash Medhi. (2019) Novel therapeutic targets for amyotrophic lateral sclerosis. Indian Journal of Pharmacology 51:6, pages 418.
Crossref
Crossref
Vijay Kumar, Tara Kashav & Md. Imtaiyaz Hassan. 2019. Pathology, Prevention and Therapeutics of Neurodegenerative Disease. Pathology, Prevention and Therapeutics of Neurodegenerative Disease
207
224
.
Teodorico C. Ramalho, Alexandre A. de Castro, Tássia S. Tavares, Maria C. Silva, Daniela R. Silva, Pedro H. Cesar, Lucas A. Santos, Elaine F.F. da Cunha, Eugenie Nepovimova & Kamil Kuca. (2018) Insights into the pharmaceuticals and mechanisms of neurological orphan diseases: Current Status and future expectations. Progress in Neurobiology 169, pages 135-157.
Crossref
Crossref
Jiayi Zhu, Lan Shen, Xiao Lin, Yanlong Hong & Yi Feng. (2017) Clinical Research on Traditional Chinese Medicine compounds and their preparations for Amyotrophic Lateral Sclerosis. Biomedicine & Pharmacotherapy 96, pages 854-864.
Crossref
Crossref
Roland Patai, Melinda Paizs, Massimo Tortarolo, Caterina Bendotti, Izabella Obál, József I. Engelhardt & László Siklós. (2017) Presymptomatically applied AMPA receptor antagonist prevents calcium increase in vulnerable type of motor axon terminals of mice modeling amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1863:7, pages 1739-1748.
Crossref
Crossref
Giovanna Morello, Antonio Gianmaria Spampinato, Francesca Luisa Conforti, Velia D’Agata & Sebastiano Cavallaro. (2017) Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach. Journal of Molecular Neuroscience 61:4, pages 563-580.
Crossref
Crossref
Roland Patai, Bernát Nógrádi, József I. Engelhardt & László Siklós. (2017) Calcium in the pathomechanism of amyotrophic lateral sclerosis – Taking center stage?. Biochemical and Biophysical Research Communications 483:4, pages 1031-1039.
Crossref
Crossref
Vijay Kumar, Asimul Islam, Md. Imtaiyaz Hassan & Faizan Ahmad. (2016) Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. European Journal of Medicinal Chemistry 121, pages 903-917.
Crossref
Crossref
Ashish Dhir & Vishal Chavda. (2016) Pre- and post-exposure talampanel (GYKI 53773) against kainic acid seizures in neonatal rats. Pharmacological Reports 68:1, pages 190-195.
Crossref
Crossref
Anastasios Fotinos, Yongjin Zhu, Lilly L. J. Mao, Nazem Atassi, Edward W. Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit E. Cudkowicz & Xin Wang. 2016. Melatonin, Neuroprotective Agents and Antidepressant Therapy. Melatonin, Neuroprotective Agents and Antidepressant Therapy
869
903
.
Giovanna Morello & Sebastiano Cavallaro. (2015) Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy. Future Medicinal Chemistry 7:10, pages 1335-1359.
Crossref
Crossref
Michael Jablonski, David S. Miller, Piera Pasinelli & Davide Trotti. (2015) ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis. Brain Research 1607, pages 1-14.
Crossref
Crossref
Alvaro Takeo Omori, Camila de Souza de Oliveira, Kleber Tellini Andrade & Marina Gonçalves Capeletto. (2015) Sassafras oil, carrot bits and microwaves: green lessons learned from the formal total synthesis of (−)-talampanel. RSC Advances 5:125, pages 103563-103565.
Crossref
Crossref
Rachna S. Pandya, Haining Zhu, Wei Li, Robert Bowser, Robert M. Friedlander & Xin Wang. (2013) Therapeutic neuroprotective agents for amyotrophic lateral sclerosis. Cellular and Molecular Life Sciences 70:24, pages 4729-4745.
Crossref
Crossref
Philip McGoldrick, Peter I. Joyce, Elizabeth M.C. Fisher & Linda Greensmith. (2013) Rodent models of amyotrophic lateral sclerosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1832:9, pages 1421-1436.
Crossref
Crossref
Philip K.-Y. Chang, David Verbich & R. Anne McKinney. (2012) AMPA receptors as drug targets in neurological disease - advantages, caveats, and future outlook. European Journal of Neuroscience 35:12, pages 1908-1916.
Crossref
Crossref